LB Pharmaceuticals grants 200,000-share option inducement awards to new CMO, CFO
Bitget2026/10/09 20:42LB Pharmaceuticals granted stock options to new executives Susan G. Kozauer and Joseph Miller on Oct. 9, 2026. Each option covers 200,000 shares, priced at $37.22 per share, with a 10-year term. Vesting runs over four years: 25% after one year, then monthly in equal installments, contingent on continued service. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610091642PRIMZONEFULLFEED9843254) on October 09, 2026, and is solely responsible for the information contained therein.
- LB Pharmaceuticals granted stock options to new executives Susan G. Kozauer and Joseph Miller on Oct. 9, 2026.
- Each option covers 200,000 shares, priced at $37.22 per share, with a 10-year term.
- Vesting runs over four years: 25% after one year, then monthly in equal installments, contingent on continued service.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Circle mintes 250 million new USDC to USDC Treasury

Michael Saylor releases Bitcoin Tracker information again, possibly hinting at increased BTC holdings


Abraxas Capital withdrew 11,200 bitcoins from the exchange, worth approximately $670 million.